ENGN

NASD enGene Therapeutics Inc.
Sep 29, 2026 · 4:15 AM ET EOD Market Closed

$1.97 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.97, $0.01 below the day’s high of $1.98

YTD change
-78.18%
vs 20-day SMA
+4.29%
vs 200-day SMA
-62.38%

Price ranges

Previous day
$1.90 $1.98
open $1.96 close $1.97
+$0.01 (+0.51%)
Today
$1.90 $1.98
$1.97
Past week
$1.88 $2.08
from $1.91 now $1.97
+$0.06 (+3.14%)
Past month
$1.76 $2.08
from $1.91 now $1.97
+$0.06 (+3.14%)
This year
$1.40 $12.25
from $9.03 now $1.97
-$7.06 (-78.18%)

Price & Performance

-4.21 (-68.12%) / 6M

$0.8472$3.71$6.58$9.44Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 95.4% away from all-time highs of $43.00
  • ENGN is down 78% since the beginning of the year
  • ENGN is down 70% over the past 12 months
  • ENGN is up 3% over the past 1 month
  • 2% of all ENGN investors are betting against ENGN

ENGN reads neutral: price sits above one of the two key moving averages, the 12-month move is -69.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.47
Earnings momentum -2.7% Quarterly EPS growth
Quarterly change -2.7%

Valuation

P/E ratio N/A
Enterprise value $-96448200.0
Beta -0.62

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$266.4M
Debt$33.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $132.0M

enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.00 +2.66%
ARGX argenx SE Sponsored ADR $972.25 +1.33%
ONC BeOne Medicines Ltd. Sponsored ADR $367.00 +1.70%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.66 +0.07%
INCY Incyte Corporation $124.82 +0.75%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.